Ajak, Hungary

Levente Szuros

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Teva Pharmaceutical Works Ltd.. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Levente Szuros. Retrieved from https://idiyas.com/inventor/levente-szuros

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Levente Szuros: Innovator in Pharmaceutical Science

Introduction

Levente Szuros is a notable inventor based in Ajak, Hungary. He has made significant contributions to the field of pharmaceutical science, particularly through his innovative work on solid state forms of fidaxomycin.

Latest Patents

Szuros holds a patent for "Solid state forms of fidaxomycin and processes for preparation thereof." This invention provides solid state forms of fidaxomycin, along with processes for preparing these forms. The patent also includes pharmaceutical compositions and formulations that incorporate one or more of the solid state forms of fidaxomycin. The solid state forms exhibit advantageous properties such as improved reliability, reproducibility in manufacturing, and stability in formulations.

Career Highlights

Levente Szuros is associated with Teva Pharmaceutical Works Ltd., where he applies his expertise in pharmaceutical development. His work has contributed to advancements in the formulation and stability of important medications.

Collaborations

Szuros has collaborated with notable colleagues, including Tamas Fonagy and Adrienne Kovacsne-Mezei, enhancing the impact of his research and innovations.

Conclusion

Levente Szuros is a distinguished inventor whose work in the pharmaceutical industry has led to significant advancements in drug formulation and stability. His contributions continue to influence the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…